173 related articles for article (PubMed ID: 31447110)
1. Balance of Active, Passive, and Anatomical Cardiac Properties in Doxorubicin-Induced Heart Failure.
Lewalle A; Land S; Merken JJ; Raafs A; Sepúlveda P; Heymans S; Kleinjans J; Niederer SA
Biophys J; 2019 Dec; 117(12):2337-2348. PubMed ID: 31447110
[TBL] [Abstract][Full Text] [Related]
2. Early myocardial changes induced by doxorubicin in the nonfailing dilated ventricle.
Rodrigues PG; Miranda-Silva D; Costa SM; Barros C; Hamdani N; Moura C; Mendes MJ; Sousa-Mendes C; Trindade F; Fontoura D; Vitorino R; Linke WA; Leite-Moreira AF; Falcão-Pires I
Am J Physiol Heart Circ Physiol; 2019 Mar; 316(3):H459-H475. PubMed ID: 30525890
[TBL] [Abstract][Full Text] [Related]
3. Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood.
Lipshultz SE; Colan SD; Gelber RD; Perez-Atayde AR; Sallan SE; Sanders SP
N Engl J Med; 1991 Mar; 324(12):808-15. PubMed ID: 1997853
[TBL] [Abstract][Full Text] [Related]
4. Targeting Extracellular Heat Shock Protein 70 Ameliorates Doxorubicin-Induced Heart Failure Through Resolution of Toll-Like Receptor 2-Mediated Myocardial Inflammation.
Liu P; Bao HY; Jin CC; Zhou JC; Hua F; Li K; Lv XX; Cui B; Hu ZW; Zhang XW
J Am Heart Assoc; 2019 Oct; 8(20):e012338. PubMed ID: 31576776
[TBL] [Abstract][Full Text] [Related]
5. Screening for
Chakouri N; Farah C; Matecki S; Amedro P; Vincenti M; Saumet L; Vergely L; Sirvent N; Lacampagne A; Cazorla O
Theranostics; 2020; 10(18):8130-8142. PubMed ID: 32724462
[TBL] [Abstract][Full Text] [Related]
6. Lingguizhugan decoction attenuates doxorubicin-induced heart failure in rats by improving TT-SR microstructural remodeling.
Li X; Xu G; Wei S; Zhang B; Yao H; Chen Y; Liu W; Wang B; Zhao J; Gao Y
BMC Complement Altern Med; 2019 Dec; 19(1):360. PubMed ID: 31829159
[TBL] [Abstract][Full Text] [Related]
7. Cardiac safety profile of patients receiving high cumulative doses of pegylated-liposomal doxorubicin: use of left ventricular ejection fraction is of unproven value.
Skubitz KM; Blaes AH; Konety SH; Francis GS
Cancer Chemother Pharmacol; 2017 Oct; 80(4):787-798. PubMed ID: 28856562
[TBL] [Abstract][Full Text] [Related]
8. TLR2 and TLR3 expression as a biomarker for the risk of doxorubicin-induced heart failure.
Liang S; Xinyong C; Hongmin Z; Jing W; Lang H; Ping Z
Toxicol Lett; 2018 Oct; 295():205-211. PubMed ID: 29959987
[TBL] [Abstract][Full Text] [Related]
9. Ablation of cardiac TIGAR preserves myocardial energetics and cardiac function in the pressure overload heart failure model.
Okawa Y; Hoshino A; Ariyoshi M; Kaimoto S; Tateishi S; Ono K; Uchihashi M; Iwai-Kanai E; Matoba S
Am J Physiol Heart Circ Physiol; 2019 Jun; 316(6):H1366-H1377. PubMed ID: 30901275
[TBL] [Abstract][Full Text] [Related]
10. Empagliflozin directly improves diastolic function in human heart failure.
Pabel S; Wagner S; Bollenberg H; Bengel P; Kovács Á; Schach C; Tirilomis P; Mustroph J; Renner A; Gummert J; Fischer T; Van Linthout S; Tschöpe C; Streckfuss-Bömeke K; Hasenfuss G; Maier LS; Hamdani N; Sossalla S
Eur J Heart Fail; 2018 Dec; 20(12):1690-1700. PubMed ID: 30328645
[TBL] [Abstract][Full Text] [Related]
11. Serial assessment of doxorubicin cardiotoxicity with quantitative radionuclide angiocardiography.
Alexander J; Dainiak N; Berger HJ; Goldman L; Johnstone D; Reduto L; Duffy T; Schwartz P; Gottschalk A; Zaret BL
N Engl J Med; 1979 Feb; 300(6):278-83. PubMed ID: 759880
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of cyclooxygenase-2 reduces hypothalamic excitation in rats with adriamycin-induced heart failure.
Zheng M; Kang YM; Liu W; Zang WJ; Bao CY; Qin DN
PLoS One; 2012; 7(11):e48771. PubMed ID: 23152801
[TBL] [Abstract][Full Text] [Related]
13. Age-related divergent remodeling of the cardiac extracellular matrix in heart failure: collagen accumulation in the young and loss in the aged.
Horn MA; Graham HK; Richards MA; Clarke JD; Greensmith DJ; Briston SJ; Hall MC; Dibb KM; Trafford AW
J Mol Cell Cardiol; 2012 Jul; 53(1):82-90. PubMed ID: 22516365
[TBL] [Abstract][Full Text] [Related]
14. Low-Dose Anthracycline and Risk of Heart Failure in a Pharmacokinetic Model of Human Myocardium Exposure: Analog Specificity and Role of Secondary Alcohol Metabolites.
Salvatorelli E; Menna P; Chello M; Covino E; Minotti G
J Pharmacol Exp Ther; 2018 Feb; 364(2):323-331. PubMed ID: 29222131
[TBL] [Abstract][Full Text] [Related]
15. Preservation of cardiac contractility after long-term therapy with oxypurinol in post-ischemic heart failure in mice.
Tan Z; Dai T; Zhong X; Tian Y; Leppo MK; Gao WD
Eur J Pharmacol; 2009 Oct; 621(1-3):71-7. PubMed ID: 19737552
[TBL] [Abstract][Full Text] [Related]
16. Serial assessment of doxorubicin cardiotoxicity in pediatric patients with quantitative radionuclide angiocardiography.
Moodie DS; Dyment PG; Napoli C; Cook SA
Cleve Clin Q; 1980; 47(4):327-31. PubMed ID: 7471466
[No Abstract] [Full Text] [Related]
17. Microstructurally Motivated Constitutive Modeling of Heart Failure Mechanics.
Hasaballa AI; Wang VY; Sands GB; Wilson AJ; Young AA; LeGrice IJ; Nash MP
Biophys J; 2019 Dec; 117(12):2273-2286. PubMed ID: 31653449
[TBL] [Abstract][Full Text] [Related]
18. Isoproterenol sensitivity of isolated cardiac myocytes from rats with monocrotaline-induced right-sided hypertrophy and heart failure.
Vescovo G; Jones SM; Harding SE; Poole-Wilson PA
J Mol Cell Cardiol; 1989 Oct; 21(10):1047-61. PubMed ID: 2555526
[TBL] [Abstract][Full Text] [Related]
19. Advantages of prophylactic versus conventionally scheduled heart failure therapy in an experimental model of doxorubicin-induced cardiomyopathy.
Lódi M; Priksz D; Fülöp GÁ; Bódi B; Gyöngyösi A; Nagy L; Kovács Á; Kertész AB; Kocsis J; Édes I; Csanádi Z; Czuriga I; Kisvárday Z; Juhász B; Lekli I; Bai P; Tóth A; Papp Z; Czuriga D
J Transl Med; 2019 Jul; 17(1):229. PubMed ID: 31324258
[TBL] [Abstract][Full Text] [Related]
20. [Metilin Improves Сardiac Function in Rabbits With Chronic Heart Failure].
Studneva IM; Lakomkin VL; Veselova OM; Prosvirnin AV; Abramov AA; Pavlovich ER; Lubimov RO; Gramovich VV; Vyborov ON; Pisarenko OI; Kapelko VI
Kardiologiia; 2018 Jul; 58(7):66-74. PubMed ID: 30081811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
